Sonirab-IT Capsule PR
Marketer
Ronyd Healthcare Pvt Ltd
Salt Composition
Rabeprazole (20mg) + Itopride (150mg)
Overview Sonirab-IT Capsule PR
Gastro-esophageal reflux disease (GERD) and peptic ulcers are effectively managed by the combined-action formula in Sonirab-IT PR Capsules. This medication alleviates common symptoms like heartburn, abdominal pain, and irritation by neutralizing stomach acid and facilitating gas expulsion. Dosage and treatment duration for Sonirab-IT PR Capsules should strictly follow your physician's instructions, varying based on individual response and condition severity. Premature discontinuation may lead to symptom recurrence and disease exacerbation. Always inform your doctor about all concurrent medications, as interactions are possible. Common, usually transient side effects include abdominal discomfort, altered bowel habits (diarrhea or constipation), headache, flatulence, fatigue, and hypersalivation. Report any concerning side effects immediately to your healthcare provider. Drowsiness and dizziness are potential side effects; avoid driving or activities requiring alertness until their impact is known. Alcohol consumption should be avoided due to potential increased sedation. Lifestyle adjustments, such as consuming cool milk and avoiding caffeinated beverages, spicy foods, and chocolate, can improve outcomes. Prior to commencing treatment, disclose any existing liver conditions, pregnancy, pregnancy intentions, or breastfeeding to your doctor.
Primary Ingredients of Sonirab-IT Capsule PR
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Sonirab-IT Capsule PR
Stomach acid disorders encompassing both reflux and peptic ulcers.
Major Benefits of Sonirab-IT Capsule PR:
Follow your physician's instructions or consult the product label for usage guidelines. Administer Sonirab-IT Capsule PR on an empty stomach.
Common Side effects of Sonirab-IT Capsule PR:
- Stomach pain
- Diarrhea
- Constipation
- Headache
- Dizziness
- Flatulence
- Weakness
- Flu-like symptoms
- Increased saliva production
How to use Sonirab-IT Capsule PR:
Follow your doctor's instructions or consult the product label for usage guidelines. Administer Sonirab-IT Capsule PR on an empty stomach.
How Sonirab-IT Capsule PR works:
Sonirab-IT Capsule PR unites Rabeprazole and Itopride to address digestive discomfort. Rabeprazole, a proton pump inhibitor (PPI), lessens stomach acid production, providing relief from heartburn and acid indigestion. Itopride, a prokinetic agent, targets brain centers regulating emesis and enhances gastrointestinal motility, facilitating efficient food passage.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when combining Sonirab-IT Capsule PR and alcohol. Seek medical advice before doing so.
PregnancyCONSULT YOUR DOCTOR
The use of Sonirab-IT Capsule PR during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to the fetus. A physician will assess the advantages against potential hazards prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Data on Sonirab-IT Capsule PR use while breastfeeding is lacking. Seek medical advice from your physician.
DrivingUNSAFE
Sonirab-IT Capsule PR may cause drowsiness, blurred vision, and dizziness, reducing alertness. Driving should be avoided if these effects are experienced.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding Sonirab-IT Capsule PR use in individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
Patients with significant hepatic impairment should use Sonirab-IT Capsule PR cautiously. Dosage modification of Sonirab-IT Capsule PR might be necessary. Physician consultation is advised.
What if you forget to take Sonirab-IT Capsule PR :
Should you forget a Sonirab-IT Capsule PR dose, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual regimen. Never take a double dose.
Facts to Know About Sonirab-IT Capsule PR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |



